[HTML][HTML] Nimotuzumab combined with irradiation enhances the inhibition to the HPV16 E6-promoted growth of cervical squamous cell carcinoma
Z Xu, H Shu, F Zhang, W Luo, Y Li, J Chu… - Frontiers in …, 2020 - frontiersin.org
Human papillomavirus (HPV) 16 E6 has been proved to increase the radiosensitivity and
lead to the EGFR overexpression in cervical cancer cells. In this study, to investigate the …
lead to the EGFR overexpression in cervical cancer cells. In this study, to investigate the …
[HTML][HTML] Nimotuzumab Combined With Irradiation Enhances the Inhibition to the HPV16 E6-Promoted Growth of Cervical Squamous Cell Carcinoma
Z Xu, H Shu, F Zhang, W Luo, Y Li, J Chu… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Abstract Human papillomavirus (HPV) 16 E6 has been proved to increase the
radiosensitivity and lead to the EGFR overexpression in cervical cancer cells. In this study, to …
radiosensitivity and lead to the EGFR overexpression in cervical cancer cells. In this study, to …
Nimotuzumab Combined With Irradiation Enhances the Inhibition to the HPV16 E6-Promoted Growth of Cervical Squamous Cell Carcinoma
Z Xu, H Shu, F Zhang, W Luo, Y Li… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Human papillomavirus (HPV) 16 E6 has been proved to increase the radiosensitivity and
lead to the EGFR overexpression in cervical cancer cells. In this study, to investigate the …
lead to the EGFR overexpression in cervical cancer cells. In this study, to investigate the …
Nimotuzumab Combined With Irradiation Enhances the Inhibition to the HPV16 E6-Promoted Growth of Cervical Squamous Cell Carcinoma.
Z Xu, H Shu, F Zhang, W Luo, Y Li, J Chu… - Frontiers in …, 2020 - europepmc.org
Abstract Human papillomavirus (HPV) 16 E6 has been proved to increase the
radiosensitivity and lead to the EGFR overexpression in cervical cancer cells. In this study, to …
radiosensitivity and lead to the EGFR overexpression in cervical cancer cells. In this study, to …